首页> 美国卫生研究院文献>Cancer Medicine >Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S‐phase arrest and promoting apoptosis through CHK1 pathway
【2h】

Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S‐phase arrest and promoting apoptosis through CHK1 pathway

机译:Mus81敲低可通过诱导S期阻滞并通过CHK1途径促进细胞凋亡来提高肝癌细胞的化学敏感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As a critical endonuclease in DNA repair, Mus81 is traditionally regarded as a tumor suppressor, but recently correlated with the sensitivity of mitomycin C and 5‐fluorouracil in colon cancer and breast cancer cells. However, its role in chemosensitivity of other human malignancies still remains unknown. This study therefore aims to investigate the effects of Mus81 knockdown on the chemosensitivity of hepatocellular carcinoma (HCC), a usually chemorefractory tumor, and explore the underlying mechanisms. Mus81 expression in HepG2 and Bel‐7402 HCC cell lines was depleted by lentivirus‐mediated short hairpin RNA and the elevated sensitivity of these Mus81‐inhibited HCC cells to therapeutic agents, especially to epirubicin (EPI), was evidenced by MTT assay and an HCC chemotherapy mouse model. Flow cytometric analysis also showed that Mus81 knockdown lead to an obvious S‐phase arrest and an elevated apoptosis in EPI‐treated HepG2 and Bel‐7402 cells, which could be rescued by CHK1 inhibition. The activation of CHK1/CDC25A/CDK2 pathway was also demonstrated in Mus81‐inhibited HepG2 cells and xenograft mouse tumors under EPI treatment. Meanwhile, the apoptosis of HepG2 cells in response to EPI was remarkably promoted by Mus81 knockdown through activating p53/Bax/Caspase‐3 pathway under the controlling of CHK1. In addition, style="fixed-case">CHK2 inhibition slightly raised style="fixed-case">CHK1 activity, thereby enhancing the S‐phase arrest and apoptosis induced by style="fixed-case">EPI in Mus81‐suppressed style="fixed-case">HCC cells. In conclusion, Mus81 knockdown improves the chemosensitivity of style="fixed-case">HCC cells by inducing S‐phase arrest and promoting apoptosis through style="fixed-case">CHK1 pathway, suggesting Mus81 as a novel therapeutic target for style="fixed-case">HCC.
机译:作为DNA修复中的关键核酸内切酶,Mus81传统上被视为一种肿瘤抑制因子,但最近与丝裂霉素C和5-氟尿嘧啶在结肠癌和乳腺癌细胞中的敏感性相关。然而,其在其他人类恶性肿瘤的化学敏感性中的作用仍然未知。因此,本研究旨在研究Mus81基因敲低对通常为化学难治性肿瘤的肝细胞癌(HCC)的化学敏感性的影响,并探讨其潜在机制。慢病毒介导的短发夹RNA耗尽了HepG2和Bel‐7402 HCC细胞系中Mus81的表达,MTT分析和HCC证明了这些被Mus81抑制的HCC细胞对治疗剂,特别是对表柔比星(EPI)的敏感性提高。化疗小鼠模型。流式细胞仪分析还显示,Mus81敲低导致EPI处理的HepG2和Bel-7402细胞明显的S期停滞和凋亡增加,可以通过CHK1抑制来挽救。在EPI处理下,在Mus81抑制的HepG2细胞和异种移植小鼠肿瘤中也证实了CHK1 / CDC25A / CDK2途径的激活。同时,在CHK1的控制下,通过激活p53 / Bax / Caspase-3通路,Mus81敲低可显着促进HepG2细胞对EPI的凋亡。此外, style =“ fixed-case”> CHK 2抑制作用略微提高了 style =“ fixed-case”> CHK 1活性,从而增强了S期阻滞和诱导的细胞凋亡由 style =“ fixed-case”> EPI 在Mus81抑制的 style =“ fixed-case”> HCC 细胞中进行。总之,Mus81敲低通过诱导S期阻滞并通过 style =“ fixed-case”> CHK 促进细胞凋亡,从而改善 style =“ fixed-case”> HCC 细胞的化学敏感性。 1途径,表明Mus81是 style =“ fixed-case”> HCC 的新型治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号